- pause slideshow
William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.
UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription
If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.
Defining clinical pharmacy: a new paradigm Subscription
Amid the rapid change and evolution of pharmacy, now is the time to redefine what clinical pharmacy means.
Time to redefine pharmacy researchSubscription
There is no universal definition of pharmacy research, and this may be one of the reasons for poor quality research in the sector.
Reclassifying emergency hormonal contraception levonorgestrel from a pharmacy to general sale medicine is not the answerSubscription
Instead of making levonorgestrel available to purchase in any retail outlet without medical advice, it would be better to improve emergency hormonal contraception consultations, lower the price of the medicine and make it more easily accessible via national patient group directions.
A decision on whether to fund HIV prevention treatment on the NHS should be based on the evidence, not politics.
Ending homeopathy funding on the NHSSubscription
The funding of homeopathic products on the NHS must stop – and not just for financial reasons.
The UK government’s documents on funding cuts for community pharmacy are inconsistent and lack evidence.
Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com
Caution is required when prescribing or dispensing long-acting beta agonists to manage airways diseases, such as asthma.
Since the dawn of hormonal replacement therapy — now known as menopausal hormone therapy — there have been conflicting reports about its risks and safety. A thorough examination of the evidence suggests it can be used safely in menopausal women.
Approval of the first over-the-counter topical retinoid in the United States is a welcome move and should be replicated in other countries.
Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.
Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.
In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.
Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription
Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.
Best pharmacy practice guidance Subscription
ASHP best practices 2016–2017: position and guidance documents of ASHP, by Bruce Hawkins
Marijuana: a short history by John Hudak.
Handbook on injectable drugs 19th edition, Editor-in-chief Gerald K McEvoy
A new perspective on addictionSubscription
Unbroken brain: a revolutionary new way of understanding addiction, by Maia Szalavitz.
The 2017 Royal Pharmaceutical Society (RPS) budget, agreed in November 2016, includes a financial surplus of £5,000 before interest. Here Simon Redman, director of finance at the RPS, talks to Julia Robinson about how the RPS has recovered from last year’s budgeted loss of £1.5m and what plans are being made to improve services and engage with members in the coming year.
Sandra Gidley, chair of the RPS English Pharmacy Board, makes the case for the integration of health and social care funding and explains why pharmacists are needed across the entire health and social care system and at all levels of the NHS.
David Branford, member of the Royal Pharmaceutical Society (RPS) English Pharmacy Board, and Dolly Sud, specialist mental health pharmacist Leicestershire Partnership NHS Trust, explain the importance of the role of pharmacists in improving the physical well-being of patients with severe mental illness.
Pharmacists can help improve the care of patients with long-term conditions across Great BritainSubscription
On 3 November 2016, the RPS launched its campaign on long-term conditions. Here, the chairs of the three RPS national pharmacy boards highlight the significance of the campaign and how it needs to be actioned in their respective countries.
The myth of the male menopauseSubscription
My old friend and fellow pharmacist Sid Dajani has been making passionate pleas on your pages and elsewhere for pharmacists to identify testosterone deficiency (Pharmaceutical Journal 2016;297:364). He is confident that, among men of a certain age, a dangerous lack of male hormone puts them at perilous ...
Asthma patients deserve better careSubscription
The 2016 Asthma UK annual asthma survey has produced some shocking findings. There are 5.4 million people in the UK diagnosed with asthma, but we found that two-thirds were not receiving the basic care that they need in order to stay well.
The recent decision in Australia to make codeine-containing medications prescription only from 2018 (The Pharmaceutical Journal online, 23 December 2016) was reported to have been met with disappointment from the Pharmaceutical Society of Australia.
I read with interest about the proposed change to the conscience clause for pharmacists (The Pharmaceutical Journal online, 22 December 2016). This concerns me.
Additional funding for R&D post-Brexit is a welcome move from the UK government, but there are other related issues to consider as well.
A round up of the most popular news stories of 2016.
In a climate where science and facts appear to play second fiddle to post-truth rants on social media, Cynthia Leifer explains why activism and public engagement must become part of the everyday work of scientists and physicians.
Natasha Leeson provides the most popular learning and CPD articles published in The Pharmaceutical Journal and Clinical Pharmacist in 2016.
Thomas Geoffrey Booth (1928-2016)Subscription
Thomas Geoffrey Booth, past president of the Royal Pharmaceutical Society, founded the UK’s first department of pharmacy practice.
Frank P Palopoli (1922–2016) Subscription
The scientist who discovered the fertility drug clomifene was known as a modest man who mentored his staff.
Kirit Patel (1949-2016)Subscription
A self-made man who started out wanting to own a shop to support his family, Kirit Patel’s lifetime achievements are inspirational.
Philip Majerus (1936-2016)Subscription
Majerus was one of the first researchers who discovered the benefits of low dose aspirin in preventing heart attacks and strokes.